Vergoeding 2020-2024 voor ATC-subgroep A10BH : Dipeptidylpeptidase-4-remmers
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| A10BH01 Sitagliptine (Januvia ®) | 10.550.800 | 10.431.900 | 10.661.700 | 7.800.700 | 6.321.500 |
| A10BH02 Vildagliptine (Galvus ®) | 1.431.100 | 1.229.900 | 1.121.600 | 1.052.900 | 903.510 |
| A10BH03 Saxagliptine (Onglyza ®) | 350.170 | 298.160 | 270.100 | 232.040 | 205.020 |
| A10BH05 Linagliptine (Trajenta ®) | 3.282.900 | 3.248.800 | 3.429.100 | 3.163.500 | 2.797.400 |
| Totaal | 15.614.970 | 15.208.760 | 15.482.500 | 12.249.140 | 10.227.430 |